Skip to main content

. 1986 Mar 11;14(5):2408. doi: 10.1093/nar/14.5.2408

Antithrombin III tours gene: identification of a point mutation leading to an arginine----cysteine replacement in a silent deficiency.

N Duchange, J F Chassé, G N Cohen, M M Zakin

PMCID: PMC339667 PMID: 3960724

2408

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Chasse J. F., Esnard F., Guitton J. D., Mouray H., Perigois F., Fauconneau G., Gauthier F. An abnormal plasma antithrombin with no apparent affinity for heparin. Thromb Res. 1984 May 15;34(4):297–302. doi: 10.1016/0049-3848(84)90386-4. [DOI] [PubMed] [Google Scholar]
Huynh-Dinh T., Duchange N., Zakin M. M., Lemarchand A., Igolen J. Modified oligonucleotides as alternatives to the synthesis of mixed probes for the screening of cDNA libraries. Proc Natl Acad Sci U S A. 1985 Nov;82(22):7510–7514. doi: 10.1073/pnas.82.22.7510. [DOI] [PMC free article] [PubMed] [Google Scholar]
Koide T., Odani S., Takahashi K., Ono T., Sakuragawa N. Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability. Proc Natl Acad Sci U S A. 1984 Jan;81(2):289–293. doi: 10.1073/pnas.81.2.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
Prochownik E. V., Markham A. F., Orkin S. H. Isolation of a cDNA clone for human antithrombin III. J Biol Chem. 1983 Jul 10;258(13):8389–8394. [PubMed] [Google Scholar]
Sakuragawa N., Takahashi K., Kondo S., Koide T. Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis. Thromb Res. 1983 Jul 15;31(2):305–317. doi: 10.1016/0049-3848(83)90333-x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES